| HER kinase inhibition in patients with HER2-and HER3-mutant cancers DM Hyman, SA Piha-Paul, H Won, J Rodon, C Saura, GI Shapiro, D Juric, ... Nature 554 (7691), 189-194, 2018 | 713 | 2018 |
| miR-21 as a key regulator of oncogenic processes SD Selcuklu, MTA Donoghue, C Spillane Biochemical Society Transactions 37 (4), 918-925, 2009 | 603 | 2009 |
| Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid AM Miller, RH Shah, EI Pentsova, M Pourmaleki, S Briggs, N Distefano, ... Nature 565 (7741), 654-658, 2019 | 480 | 2019 |
| Tumour lineage shapes BRCA-mediated phenotypes P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, ... Nature 571 (7766), 576-579, 2019 | 364 | 2019 |
| Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid EI Pentsova, RH Shah, J Tang, A Boire, D You, S Briggs, A Omuro, X Lin, ... Journal of clinical oncology 34 (20), 2404-2415, 2016 | 364 | 2016 |
| AKT Inhibition in Solid Tumors With AKT1 Mutations DM Hyman, LM Smyth, MTA Donoghue, SN Westin, PL Bedard, EJ Dean, ... Journal of Clinical Oncology 35 (20), 2251-2259, 2017 | 297 | 2017 |
| MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells SD Selcuklu, MTA Donoghue, K Rehmet, M de Souza Gomes, A Fort, ... Journal of Biological Chemistry 287 (35), 29516-29528, 2012 | 233 | 2012 |
| Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma JJ Hsieh, D Chen, PI Wang, M Marker, A Redzematovic, YB Chen, ... European urology 71 (3), 405-414, 2017 | 214 | 2017 |
| Resistance to TRK inhibition mediated by convergent MAPK pathway activation E Cocco, AM Schram, A Kulick, S Misale, HH Won, R Yaeger, P Razavi, ... Nature medicine 25 (9), 1422-1427, 2019 | 184 | 2019 |
| Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition JJ Harding, MA Lowery, AH Shih, JM Schvartzman, S Hou, C Famulare, ... Cancer discovery 8 (12), 1540-1547, 2018 | 171 | 2018 |
| Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer LM Smyth, SA Piha-Paul, HH Won, AM Schram, C Saura, S Loi, J Lu, ... Cancer discovery 10 (2), 198-213, 2020 | 111 | 2020 |
| Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM-and PUMA-mediated apoptosis K Tanaka, AY Helena, S Yang, S Han, SD Selcuklu, K Kim, S Ramani, ... Cancer Cell 39 (9), 1245-1261. e6, 2021 | 81 | 2021 |
| Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non–clear cell renal cell carcinoma MH Voss, AM Molina, YB Chen, KM Woo, JL Chaim, DT Coskey, ... Journal of Clinical Oncology 34 (32), 3846-3853, 2016 | 81 | 2016 |
| An NTD‐Associated Polymorphism in the 3′ UTR of MTHFD 1 L can Affect Disease Risk by Altering mi RNA Binding S Minguzzi, SD Selcuklu, C Spillane, A Parle‐McDermott Human Mutation 35 (1), 96-104, 2014 | 52 | 2014 |
| An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions SD Selcuklu, MC Yakicier, AE Erson Cancer genetics and cytogenetics 189 (1), 15-23, 2009 | 49 | 2009 |
| Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway MM Rubinstein, DM Hyman, I Caird, H Won, K Soldan, K Seier, A Iasonos, ... Cancer 126 (6), 1274-1282, 2020 | 46 | 2020 |
| Noninvasive detection of polyclonal acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations AM Varghese, J Patel, YY Janjigian, F Meng, SD Selcuklu, G Iyer, ... JCO Precision Oncology 5, 44-50, 2021 | 39 | 2021 |
| Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients DWY Tsui, ML Cheng, M Shady, JL Yang, D Stephens, H Won, ... Genome medicine 13 (1), 96, 2021 | 37 | 2021 |
| Regulatory interplay between miR-21, JAG1 and 17beta-estradiol (E2) in breast cancer cells SD Selcuklu, MTA Donoghue, MJ Kerin, C Spillane Biochemical and biophysical research communications 423 (2), 234-239, 2012 | 35 | 2012 |
| Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs ML Cheng, MTA Donoghue, F Audenet, NC Wong, EJ Pietzak, CM Bielski, ... JCO Precision Oncology 4, 1307-1320, 2020 | 15 | 2020 |
